Skip to main content
. 2022 Dec;33(12):2211–2231. doi: 10.1681/ASN.2022030286

Table 2.

Description of the quantitative and qualitative characteristics of patients with multiple sclerosis (mean ± SD or n [percentage])

Characteristics n (%) or mean ± SD
Men/women 2/9
Age at MS diagnosis, yr 31.09±7.48
Age at blood sampling (M00), yr 39.00±7.07
Previous treatment
 IFN-β 7 (64)
 Glatiramer acetate 6 (55)
 Immunosuppressor 2 (18)
Response to natalizumab at 1 yr 11 (100)

MS, multiple sclerosis; M00, month 0 (inclusion time).